Better options needed to treat traumatic brain injury [Infographic]
by Brandpoint (ARA) Sponsored Content
Jul 23, 2013 | 42131 views | 0 0 comments | 439 439 recommendations | email to a friend | print
More Americans suffer a traumatic brain injury (TBI) each year (3.5 million) than those diagnosed with breast cancer, HIV and multiple sclerosis combined (1.6 million), according to the latest estimates from the U.S. Centers for Disease Control and Prevention. Researchers have worked diligently for decades to develop a successful acute treatment for this devastating, life-altering condition. But after scores of failed clinical trials, we still don’t have an FDA-approved treatment for TBI.

Failure to find a treatment can be partly explained by the complexity of the condition. Beyond potentially deadly damage to the brain, TBI can cause severe problems for organs throughout the body. 

Researchers are now studying a treatment that may address TBI through multiple pathways – progesterone. Although widely known as a pregnancy hormone, clinical studies have shown progesterone is made in both male and female central nervous systems and offers neurological protection.

SyNAPSe(R), a global, Phase III clinical trial, is studying the safety and efficacy of progesterone as a potential treatment for severe TBI. If the study is successful, the treatment could become the world’s first approved TBI treatment. Learn more about the promise of progesterone and the SyNAPSe trial at

Copyright 2013 The Times-Independent. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

report abuse...

Express yourself:

We're glad to give readers a forum to express their points of view on issues important to this community. That forum is the “Letters to the Editor.” Letters to the editor may be submitted directly to The Times-Independent through this link and will be published in the print edition of the newspaper. All letters must be the original work of the letter writer – form letters will not be accepted. All letters must include the actual first and last name of the letter writer, the writer’s address, city and state and telephone number. Anonymous letters will not be accepted.

Letters may not exceed 400 words in length, must be regarding issues of general interest to the community, and may not include personal attacks, offensive language, ethnic or racial slurs, or attacks on personal or religious beliefs. Letters should focus on a single issue. Letters that proselytize or focus on theological debates will not be published. During political campaigns, The Times-Independent will not publish letters supporting or opposing any local candidate. Thank you letters are generally not accepted for publication unless the letter has a public purpose. Thank you letters dealing with private matters that compliment or complain about a business or individual will not be published. Nor will letters listing the names of individuals and/or businesses that supported a cause or event. Thank you letters about good Samaritan acts will be considered at the discretion of the newspaper.